Logo image of TEVA

TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Overview

NYSE:TEVA - US8816242098 - ADR

18.46 USD
-0.34 (-1.81%)
Last: 8/22/2025, 8:04:00 PM
18.47 USD
+0.01 (+0.05%)
After Hours: 8/22/2025, 8:04:00 PM

TEVA Key Statistics, Chart & Performance

Key Statistics
52 Week High22.8
52 Week Low12.47
Market Cap21.18B
Shares1.15B
Float1.12B
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.61
PE7.07
Fwd PE6.48
Earnings (Next)11-04 2025-11-04/bmo
IPO01-01 1951-01-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


TEVA short term performance overview.The bars show the price performance of TEVA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

TEVA long term performance overview.The bars show the price performance of TEVA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80 100

The current stock price of TEVA is 18.46 USD. In the past month the price increased by 11.61%. In the past year, price decreased by -0.54%.

TEVA PHARMACEUTICAL-SP ADR / TEVA Daily stock chart

TEVA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 44.07 673.58B
JNJ JOHNSON & JOHNSON 17.93 431.79B
NVO NOVO-NORDISK A/S-SPONS ADR 14.69 253.19B
AZN ASTRAZENECA PLC-SPONS ADR 18.24 251.05B
NVS NOVARTIS AG-SPONSORED ADR 14.35 245.81B
MRK MERCK & CO. INC. 11.35 218.23B
PFE PFIZER INC 7.63 147.14B
SNY SANOFI-ADR 11.64 125.24B
BMY BRISTOL-MYERS SQUIBB CO 7.12 97.54B
GSK GSK PLC-SPON ADR 8.95 81.01B
ZTS ZOETIS INC 25.18 69.41B
TAK TAKEDA PHARMACEUTIC-SP ADR 53.52 49.02B

About TEVA

Company Profile

TEVA logo image Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Company Info

TEVA PHARMACEUTICAL-SP ADR

124 Dvora Hanevi'a St.

TEL AVIV-YAFO 49131 IL

CEO: Kare Schultz

Employees: 33892

TEVA Company Website

TEVA Investor Relations

Phone: 97239148213

TEVA PHARMACEUTICAL-SP ADR / TEVA FAQ

What is the stock price of TEVA PHARMACEUTICAL-SP ADR today?

The current stock price of TEVA is 18.46 USD. The price decreased by -1.81% in the last trading session.


What is the ticker symbol for TEVA PHARMACEUTICAL-SP ADR stock?

The exchange symbol of TEVA PHARMACEUTICAL-SP ADR is TEVA and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is TEVA stock listed?

TEVA stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for TEVA PHARMACEUTICAL-SP ADR stock?

9 analysts have analysed TEVA and the average price target is 0.05 USD. This implies a price decrease of -99.71% is expected in the next year compared to the current price of 18.46. Check the TEVA PHARMACEUTICAL-SP ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TEVA PHARMACEUTICAL-SP ADR worth?

TEVA PHARMACEUTICAL-SP ADR (TEVA) has a market capitalization of 21.18B USD. This makes TEVA a Large Cap stock.


How many employees does TEVA PHARMACEUTICAL-SP ADR have?

TEVA PHARMACEUTICAL-SP ADR (TEVA) currently has 33892 employees.


What are the support and resistance levels for TEVA PHARMACEUTICAL-SP ADR (TEVA) stock?

TEVA PHARMACEUTICAL-SP ADR (TEVA) has a support level at 16.86. Check the full technical report for a detailed analysis of TEVA support and resistance levels.


Is TEVA PHARMACEUTICAL-SP ADR (TEVA) expected to grow?

The Revenue of TEVA PHARMACEUTICAL-SP ADR (TEVA) is expected to grow by 2.75% in the next year. Check the estimates tab for more information on the TEVA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy TEVA PHARMACEUTICAL-SP ADR (TEVA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TEVA PHARMACEUTICAL-SP ADR (TEVA) stock pay dividends?

TEVA does not pay a dividend.


When does TEVA PHARMACEUTICAL-SP ADR (TEVA) report earnings?

TEVA PHARMACEUTICAL-SP ADR (TEVA) will report earnings on 2025-11-04, before the market open.


What is the Price/Earnings (PE) ratio of TEVA PHARMACEUTICAL-SP ADR (TEVA)?

The PE ratio for TEVA PHARMACEUTICAL-SP ADR (TEVA) is 7.07. This is based on the reported non-GAAP earnings per share of 2.61 and the current share price of 18.46 USD. Check the full fundamental report for a full analysis of the valuation metrics for TEVA.


What is the Short Interest ratio of TEVA PHARMACEUTICAL-SP ADR (TEVA) stock?

The outstanding short interest for TEVA PHARMACEUTICAL-SP ADR (TEVA) is 4.44% of its float. Check the ownership tab for more information on the TEVA short interest.


TEVA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to TEVA. When comparing the yearly performance of all stocks, TEVA turns out to be only a medium performer in the overall market: it outperformed 46.82% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TEVA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to TEVA. While TEVA is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TEVA Financial Highlights

Over the last trailing twelve months TEVA reported a non-GAAP Earnings per Share(EPS) of 2.61. The EPS decreased by -4.09% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.39%
ROE -2.31%
Debt/Equity 2.46
Chartmill High Growth Momentum
EPS Q2Q%8.2%
Sales Q2Q%0.29%
EPS 1Y (TTM)-4.09%
Revenue 1Y (TTM)2.07%

TEVA Forecast & Estimates

9 analysts have analysed TEVA and the average price target is 0.05 USD. This implies a price decrease of -99.71% is expected in the next year compared to the current price of 18.46.

For the next year, analysts expect an EPS growth of 5.48% and a revenue growth 2.75% for TEVA


Analysts
Analysts42.22
Price Target0.05 (-99.73%)
EPS Next Y5.48%
Revenue Next Year2.75%

TEVA Ownership

Ownership
Inst Owners6.95%
Ins Owners0.43%
Short Float %4.44%
Short Ratio4.39